951 related articles for article (PubMed ID: 19656027)
21. GCF MMP-8 levels in smokers and non-smokers with chronic periodontitis following scaling and root planing accompanied by systemic use of flurbiprofen.
Kurtis B; Tüter G; Serdar M; Pinar S; Demirel I; Toyman U
J Periodontol; 2007 Oct; 78(10):1954-61. PubMed ID: 18062117
[TBL] [Abstract][Full Text] [Related]
22. Correlation of gingival crevicular fluid interleukin-18 and monocyte chemoattractant protein-1 levels in periodontal health and disease.
Pradeep AR; Daisy H; Hadge P; Garg G; Thorat M
J Periodontol; 2009 Sep; 80(9):1454-61. PubMed ID: 19722796
[TBL] [Abstract][Full Text] [Related]
23. Short-term clinical and immunologic effects of scaling and root planing with Er:YAG laser in chronic periodontitis.
Lopes BM; Marcantonio RA; Thompson GM; Neves LH; Theodoro LH
J Periodontol; 2008 Jul; 79(7):1158-67. PubMed ID: 18597597
[TBL] [Abstract][Full Text] [Related]
24. Gingival crevicular fluid osteopontin levels in periodontal health and disease.
Sharma CG; Pradeep AR
J Periodontol; 2006 Oct; 77(10):1674-80. PubMed ID: 17032109
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-1beta and thiobarbituric acid reactive substance (TBARS) levels after phase I periodontal therapy in patients with chronic periodontitis.
Tüter G; Kurtiş B; Serdar M
J Periodontol; 2001 Jul; 72(7):883-8. PubMed ID: 11495136
[TBL] [Abstract][Full Text] [Related]
26. Partial- and full-mouth scaling and root planing in type 2 diabetic subjects: a 12-mo follow-up of clinical parameters and levels of cytokines and osteoclastogenesis-related factors.
Santos VR; Ribeiro FV; Lima JA; Miranda TS; Feres M; Bastos MF; Duarte PM
J Periodontal Res; 2012 Feb; 47(1):45-54. PubMed ID: 21806617
[TBL] [Abstract][Full Text] [Related]
27. Emerging roles of Interleukin-34 together with receptor activator of nuclear factor-kB ligand and osteoprotegerin levels in periodontal disease.
Bozkurt Doğan Ş; Öngöz Dede F; Ballı U; Sertoğlu E
Cytokine; 2021 Aug; 144():155584. PubMed ID: 34034144
[TBL] [Abstract][Full Text] [Related]
28. Effect of chronic periodontitis on serum and gingival crevicular fluid oxidant and antioxidant status in patients with familial Mediterranean fever before and after periodontal treatment.
Bostanci V; Toker H; Senel S; Ozdemir H; Aydin H
J Periodontol; 2014 May; 85(5):706-12. PubMed ID: 23826647
[TBL] [Abstract][Full Text] [Related]
29. Clinical response of azithromycin as an adjunct to non-surgical periodontal therapy in smokers.
Mascarenhas P; Gapski R; Al-Shammari K; Hill R; Soehren S; Fenno JC; Giannobile WV; Wang HL
J Periodontol; 2005 Mar; 76(3):426-36. PubMed ID: 15857078
[TBL] [Abstract][Full Text] [Related]
30. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio.
Bostanci N; Ilgenli T; Emingil G; Afacan B; Han B; Töz H; Atilla G; Hughes FJ; Belibasakis GN
J Clin Periodontol; 2007 May; 34(5):370-6. PubMed ID: 17355365
[TBL] [Abstract][Full Text] [Related]
31. Salivary-soluble CD44 levels in smokers and non-smokers with chronic periodontitis: a pilot study.
Ghallab N; Shaker O
J Periodontol; 2010 May; 81(5):710-7. PubMed ID: 20429650
[TBL] [Abstract][Full Text] [Related]
32. Clinical, microbiologic, and biochemical effects of subgingival administration of a Xanthan-based chlorhexidine gel in the treatment of periodontitis: a randomized multicenter trial.
Paolantonio M; D'Ercole S; Pilloni A; D'Archivio D; Lisanti L; Graziani F; Femminella B; Sammartino G; Perillo L; Tetè S; Perfetti G; Spoto G; Piccolomini R; Perinetti G
J Periodontol; 2009 Sep; 80(9):1479-92. PubMed ID: 19722799
[TBL] [Abstract][Full Text] [Related]
33. Cytokine levels in sites of chronic periodontitis of poorly controlled and well-controlled type 2 diabetic subjects.
Santos VR; Ribeiro FV; Lima JA; Napimoga MH; Bastos MF; Duarte PM
J Clin Periodontol; 2010 Dec; 37(12):1049-58. PubMed ID: 20874828
[TBL] [Abstract][Full Text] [Related]
34. One-stage full-mouth versus partial-mouth scaling and root planing during the effective half-life of systemically administered azithromycin.
Yashima A; Gomi K; Maeda N; Arai T
J Periodontol; 2009 Sep; 80(9):1406-13. PubMed ID: 19722790
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-1 beta, prostaglandin E2, and immunoglobulin G subclasses in gingival crevicular fluid in patients undergoing periodontal therapy.
Alexander DC; Martin JC; King PJ; Powell JR; Caves J; Cohen ME
J Periodontol; 1996 Aug; 67(8):755-62. PubMed ID: 8866314
[TBL] [Abstract][Full Text] [Related]
36. The effect of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis.
Emingil G; Atilla G; Sorsa T; Luoto H; Kirilmaz L; Baylas H
J Periodontol; 2004 Jan; 75(1):106-15. PubMed ID: 15025222
[TBL] [Abstract][Full Text] [Related]
37. Effect of periodontal treatment on receptor activator of NF-κB ligand and osteoprotegerin levels and relative ratio in gingival crevicular fluid.
Bostanci N; Saygan B; Emingil G; Atilla G; Belibasakis GN
J Clin Periodontol; 2011 May; 38(5):428-33. PubMed ID: 21261673
[TBL] [Abstract][Full Text] [Related]
38. Crevicular fluid glutathione levels in periodontitis and the effect of non-surgical therapy.
Grant MM; Brock GR; Matthews JB; Chapple IL
J Clin Periodontol; 2010 Jan; 37(1):17-23. PubMed ID: 19968740
[TBL] [Abstract][Full Text] [Related]
39. Gingival crevicular fluid alkaline phosphatase levels in postmenopausal women: effects of phase I periodontal treatment.
Daltaban O; Saygun I; Bal B; Baloş K; Serdar M
J Periodontol; 2006 Jan; 77(1):67-72. PubMed ID: 16579705
[TBL] [Abstract][Full Text] [Related]
40. Effect of initial periodontal therapy on oxidative stress markers in gingival crevicular fluid, saliva, and serum in smokers and non-smokers with chronic periodontitis.
Hendek MK; Erdemir EO; Kisa U; Ozcan G
J Periodontol; 2015 Feb; 86(2):273-82. PubMed ID: 25325515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
